U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C46H56N4O10
Molecular Weight 824.9576
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of VINCRISTINE

SMILES

[H][C@@]12N3CC[C@@]14C5=CC(=C(OC)C=C5N(C=O)[C@@]4([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]6(C[C@H]7CN(C[C@](O)(CC)C7)CCC8=C6NC9=CC=CC=C89)C(=O)OC

InChI

InChIKey=OGWKCGZFUXNPDA-CFWMRBGOSA-N
InChI=1S/C46H56N4O10/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1

HIDE SMILES / InChI
Molecular Formula C46H56N4O10
Molecular Weight 824.9576
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 8 / 9
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 14:59:52 UTC 2023
Edited
by admin
on Fri Dec 15 14:59:52 UTC 2023
Record UNII
5J49Q6B70F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
VINCRISTINE
HSDB   INN   MI   VANDF   WHO-DD  
INN  
Official Name English
(+)-VINCRISTINE
Common Name English
22-OXOVINCALEUKOBLASTINE
Common Name English
VINCALEUKOBLASTINE, 22-OXO-
Common Name English
Vincristine [WHO-DD]
Common Name English
ONCOTCS
Brand Name English
VINCRISTINE [VANDF]
Common Name English
TECNOCRIS
Brand Name English
VINCRISTINE [MI]
Common Name English
VINCRISTINE [HSDB]
Common Name English
VINKRISTIN
Common Name English
VCR
Common Name English
LEUROCRISTINE
Common Name English
LEUCRISTINE
Common Name English
vincristine [INN]
Common Name English
VINCRISTIN
Common Name English
Classification Tree Code System Code
WHO-VATC QL01CA02
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
LIVERTOX 1030
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
NCI_THESAURUS C932
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
WHO-ATC L01CA02
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 8.2
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
NDF-RT N0000007780
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
NDF-RT N0000007780
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
NCI_THESAURUS C67422
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
NDF-RT N0000175612
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
Code System Code Type Description
DRUG BANK
DB00541
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
ChEMBL
CHEMBL90555
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
EVMPD
SUB00059MIG
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
MERCK INDEX
m11453
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY Merck Index
EPA CompTox
DTXSID1032278
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
INN
1440
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
DRUG CENTRAL
2825
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-318-1
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
NCI_THESAURUS
C933
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
SMS_ID
100000079089
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
RXCUI
11202
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY RxNorm
PUBCHEM
5388993
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
DAILYMED
5J49Q6B70F
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
FDA UNII
5J49Q6B70F
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
CAS
57-22-7
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
WIKIPEDIA
VINCRISTINE
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
MESH
D014750
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
IUPHAR
6785
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
HSDB
3199
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
CHEBI
143658
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
LACTMED
Vincristine
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
CHEBI
28445
Created by admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
PRIMARY
Related Record Type Details
CYTOCHROME P450 3A4
METABOLIC ENZYME -> SUBSTRATE
CYTOCHROME P450 3A5
METABOLIC ENZYME -> SUBSTRATE
CYP3A5 was more efficient in catalyzing the formation of M1 compared with CYP3A4 (9- to 14-fold higher intrinsic clearance for CYP3A5).
MRP-3
TRANSPORTER -> SUBSTRATE
MRP-1
TRANSPORTER -> INHIBITOR
MRP-2
TRANSPORTER -> INHIBITOR
MRP-2
TRANSPORTER -> SUBSTRATE
ATP-dependent translocase ABCB1 [Canis lupus familiaris]
TRANSPORTER -> SUBSTRATE
Dogs homozygous or heterozygous for the ABCB1-1Δ mutation are significantly more likely than normal dogs to develop haematological and gastrointestinal toxicity.
MRP-1
TRANSPORTER -> SUBSTRATE
TUBULIN BETA CHAIN
TARGET -> INHIBITOR
Structure of VILANTEROL TRIFENATATE
TRANSPORTER -> SUBSTRATE
Structure of VINCRISTINE SULFATE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of VINCRISTINE METABOLITE M2
METABOLITE -> PARENT
MINOR
Related Record Type Details
Structure of VINCRISTINE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Route of Elimination PHARMACOKINETIC
Route of Elimination PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966